Kansas-based Dechra Veterinary Products LLC has informed that the company has got FDA approval to market VETORYL(R) Capsules.

Vetoryl Capsules are for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs.
 
In addition, the drug is used in the treatment of Cushing's syndrome (excess production of corticosteroids from the adrenal glands).
 
Dechra Veterinary Products LLC, is the U.S. subsidiary of Dechra Pharmaceuticals PLC, a UK listed company focused on international animal healthcare markets. The company currently markets a range of specialized veterinary products in the U.S.